COST-EFFECTIVENESS MODEL OF LEBRIKIZUMAB COMPARED TO DUPILUMAB IN THE TREATMENT OF AUSTRIAN PATIENTS WITH MODERATE TO SEVERE ATOPIC DERMATITIS

被引：0
|
作者：
Schwarz, B. [1 ]
Sole-Feu, L. [2 ]
Akmaz, B. [3 ]
机构：
[1] Med Univ Vienna, Vienna, Austria
[2] Almirall SA, Barcelona, Catalonia, Spain
[3] Pricing & Med Affairs Almirall SA, Reinbek, SH, Germany
来源：
VALUE IN HEALTH | 2024年 / 27卷 / 12期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
EE705
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Economic Evaluation of Dupilumab for the Treatment of Moderate-to-Severe Atopic Dermatitis in Adults
    Andreas Kuznik
    Gaëlle Bégo-Le-Bagousse
    Laurent Eckert
    Abhijit Gadkari
    Eric Simpson
    Christopher N. Graham
    LaStella Miles
    Vera Mastey
    Puneet Mahajan
    Sean D. Sullivan
    Dermatology and Therapy, 2017, 7 : 493 - 505
  • [42] Economic Evaluation of Dupilumab for the Treatment of Moderate-to-Severe Atopic Dermatitis in Adults
    Kuznik, Andreas
    Bego-Le-Bagousse, Gaelle
    Eckert, Laurent
    Gadkari, Abhijit
    Simpson, Eric
    Graham, Christopher N.
    Miles, LaStella
    Mastey, Vera
    Mahajan, Puneet
    Sullivan, Sean D.
    DERMATOLOGY AND THERAPY, 2017, 7 (04) : 493 - 505
  • [43] Dupilumab for the treatment of moderate and severe atopic dermatitis: real-life experience
    Sroka-Tomaszewska, Jowita
    Bulinska, Barabara
    Wilkowska, Aleksandra
    Nowicki, Roman J.
    Trzeciak, Magdalena
    POSTEPY DERMATOLOGII I ALERGOLOGII, 2023, 40 (06): : 747 - 752
  • [44] Dupilumab for Off-Label Treatment of Moderate to Severe Childhood Atopic Dermatitis
    Jorge, Emily
    Clark, Jane
    CUTIS, 2018, 102 (03): : 201 - 204
  • [45] Dupilumab Treatment Reduces Hospitalizations in Adults With Moderate-to-Severe Atopic Dermatitis
    Silverberg, Jonathan, I
    Rubini, Norma P. M.
    Pires, Mario C.
    Rossi, Ana B.
    Zhang, Annie
    Chen, Zhen
    Levit, Noah A.
    Chao, Jingdong
    Shumel, Brad
    Bego-Le Bagousse, Gaelle
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2022, 10 (05): : 1279 - +
  • [46] Treatment of Severe Atopic Dermatitis with Dupilumab in Patients with Advanced Cancer
    Tanczosova, Milena
    Hugo, Jan
    Gkalpakiotis, Spyridon
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (03)
  • [47] Dupilumab as treatment for severe recalcitrant atopic dermatitis - real life experience in an Austrian cohort
    Quint, T.
    Bangert, C.
    ALLERGY, 2019, 74 : 536 - 536
  • [48] Cost-effectiveness of mirtazapine compared to fluoxetine in the treatment of moderate and severe depression in Hungary
    Van Loon, J
    Horvath, LZ
    Faludi, G
    VALUE IN HEALTH, 2002, 5 (06) : 517 - 517
  • [49] Effect of Dupilumab on Sexual Desire in Adult Patients with Moderate to Severe Atopic Dermatitis
    Napolitano, Maddalena
    Fabbrocini, Gabriella
    Kastl, Sara
    Battista, Teresa
    Di Guida, Adriana
    Martora, Fabrizio
    Picone, Vincenzo
    Ventura, Virginia
    Patruno, Cataldo
    MEDICINA-LITHUANIA, 2022, 58 (12):
  • [50] Efficacy and tolerance of dupilumab in patients with moderate-to-severe atopic dermatitis and obesity
    Dupuis, Josephine
    Tauber, Marie
    Mahe, Emmanuel
    Jachiet, Marie
    Soria, Angele
    Tetart, Florence
    Puzenat, Eve
    Pasteur, Justine
    Raison-Peyron, Nadia
    Giordano-Labadie, Francoise
    Droitcourt, Catherine
    Leleu, Camille
    Nosbaum, Audrey
    Aubert, Helene
    Moigne, Marie L. E.
    Bernier, Claire
    Barbarot, Sebastien
    Ezzedine, Khaled
    Diaz, Emmanuelle
    Hubiche, Thomas
    Faiz, Sarah
    Azib, Selma
    Dezoteux, Frederic
    Chosidow, Olivier
    Staumont-Salle, Delphine
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2025, 39 (02) : e174 - e178
12345